More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Medical Marijuana, Inc. to Exhibit Only Federally Legal Product, Zero-THC Real Scientific Hemp Oil™, at ExpoWeed in Mexico City

Medical Marijuana, Inc. to Exhibit Only Federally Legal Product, Zero-THC Real Scientific Hemp Oil™, at ExpoWeed in Mexico City

by adminAdrianRamirez | Aug 17, 2017 | HempMeds Mexico, Press Releases

SAN DIEGO, Aug. 17, 2017 — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, announced today that it is sponsoring and exhibiting at the Aug. 18-20 ExpoWeed Conference, the largest annual cannabis conference...
Vanity Fair Mexico Article Features Medical Marijuana, Inc. Subsidiary HempMeds® Mexico’s Role in Improving Lives of Thousands of Patients

Vanity Fair Mexico Article Features Medical Marijuana, Inc. Subsidiary HempMeds® Mexico’s Role in Improving Lives of Thousands of Patients

by adminAdrianRamirez | Aug 16, 2017 | HempMeds Mexico, Press Releases

Article Also Details Company’s Growth in Mexico, Features In-Depth Interview with Company’s COO SAN DIEGO, Aug. 16, 2017 — Medical Marijuana, Inc. (MJNA) announced today that its subsidiary HempMeds® Mexico, the first Company to receive government...
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil To Hold Its Second Doctor Symposium on Medical Cannabis in Sao Paulo, Brazil

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil To Hold Its Second Doctor Symposium on Medical Cannabis in Sao Paulo, Brazil

by adminAdrianRamirez | Aug 14, 2017 | HempMeds Brasil, Press Releases

Sold-Out Event to Educate Brazilian Medical Community on Therapeutic Uses of Cannabis, Importation and Prescribing Rules to Provide Patients Greater Access SAN DIEGO, Aug. 14, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company...
HempMeds® Brasil Featured as Educational Source for Brasilians Exploring CBD

HempMeds® Brasil Featured as Educational Source for Brasilians Exploring CBD

by adminAdrianRamirez | Aug 11, 2017 | HempMeds Brasil, Media Coverage

[vc_row][vc_column][vc_column_text]Medical Marijuana, Inc. portfolio company HempMeds® Brasil was featured this week in an article about CBD oil’s growing use among patients on the nation’s popular Catraquinha website. According to the Catraquinha website, the page,...
Medical Marijuana, Inc. Announces July 2017 as Largest Revenue Sales Month in Company History

Medical Marijuana, Inc. Announces July 2017 as Largest Revenue Sales Month in Company History

by adminAdrianRamirez | Aug 8, 2017 | HempMeds Mexico, Kannaway, Press Releases

Medical Marijuana, Inc. Wholly Owned Subsidiaries Kannaway ® and HempMeds® Mexico Had the Largest Sales Month in July Since Companies Were Founded SAN DIEGO, Aug 8, 2017  — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.